PatternsRadar
Sign in

DRREDDYDr. Reddy's Laboratories Limited

NSEF&O
1,390.20INR-10.70 (-0.76%)Close · 20 Nov 2026
23 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1.16L CrMarket cap
41.5P/E (TTM)
49.2%Delivery

Filings & corporate actions

83 results filed
CSV
Next results · Q3 FY27
Expected 21 Jan 2027 – 30 Jan 2027
Estimate: filed 21–30 days after quarter end, last 5 times
Dividend
₹8.00 per share · last 10 Jul 2026
2026
  • 23 OctresultsResults · Q2 FY27 · consolidated and standalone+6.6%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026+0.2%NSE
  • 22 JulresultsResults · Q1 FY27 · consolidated and standalone-1.4%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-1.4%NSE
  • 10 JuldividendDividend · ₹8.00 per share-2.0%
  • 12 MayresultsResults · Q4 FY26 · consolidated and standalone-0.4%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-1.0%NSE
  • 21 JanresultsResults · Q3 FY26 · consolidated and standalone+5.2%NSE
  • 20 JanshareholdingShareholding · 31 Dec 20250.0%NSE

Reaction to results · all yearsrose on day 0 in 38 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2723 Oct 2026+6.6%+9.2%—4.6×
Q1 FY2722 Jul 2026-1.4%-3.2%-0.2%2.4×
Q4 FY2612 May 2026-0.4%+4.1%+0.5%3.1×
Q3 FY2621 Jan 2026+5.2%+5.3%+10.8%4.7×
Q2 FY2624 Oct 2025+0.1%-6.8%-3.7%1.0×
Q1 FY2623 Jul 2025+1.5%+1.8%+2.4%2.8×
Q4 FY259 May 2025+3.4%+5.5%+14.1%2.3×
Q3 FY2524 Jan 2025-5.0%-5.6%-9.2%4.0×
Q2 FY255 Nov 2024+2.4%-2.1%-1.5%2.7×
Q1 FY2527 Jul 2024-0.6%-1.0%+1.2%1.5×
Q4 FY247 May 2024-3.2%-6.1%-6.9%2.5×
Q3 FY2430 Jan 2024+4.8%+5.8%+10.0%4.2×
Q2 FY2427 Oct 2023-1.0%-1.1%+5.2%1.4×
Q1 FY2426 Jul 2023+0.6%+3.4%+5.5%3.6×
Q4 FY2310 May 2023-6.9%-9.1%-4.5%8.5×
Q3 FY2325 Jan 2023+2.7%+3.7%+6.9%4.1×
Q2 FY2329 Oct 2022-0.6%+0.6%-0.2%5.2×
Q1 FY2328 Jul 2022-4.0%-2.4%-0.4%4.3×
Q4 FY2219 May 2022+8.1%+11.7%+5.5%6.6×
Q3 FY2228 Jan 2022-0.9%+2.2%-1.9%3.3×
Q2 FY2229 Oct 2021+3.1%+2.9%-1.1%1.4×
Q1 FY2227 Jul 2021-10.5%-12.7%-15.9%14.8×
Q4 FY2114 May 2021-2.0%-1.6%+2.9%2.0×
Q3 FY2129 Jan 2021-5.5%-1.5%-9.1%3.8×
Q2 FY2128 Oct 2020-0.2%+0.2%-2.5%1.0×
Q1 FY2129 Jul 2020+6.2%+13.6%+9.5%6.1×
Q4 FY2020 May 2020+5.7%+5.1%+8.3%3.4×
Q3 FY2027 Jan 2020+5.2%+3.7%+1.8%8.8×
Q2 FY201 Nov 2019-1.0%+1.4%+3.2%5.8×
Q1 FY2029 Jul 2019-3.5%-3.7%-4.8%4.2×
Q4 FY1917 May 2019-5.7%-3.2%-5.6%4.5×
Q3 FY196 Feb 2019+1.1%-4.4%-6.3%0.7×
Q2 FY1929 Oct 2018+2.4%-3.2%+4.8%1.2×
Q1 FY1913 Aug 2018+1.7%+9.9%+15.2%0.6×
Q4 FY1826 May 2018+1.4%+1.4%+16.4%1.0×
Q3 FY1830 Jan 2018-3.5%-8.4%-3.2%1.8×
Q2 FY181 Nov 2017-3.0%-3.4%-6.2%2.1×
Q1 FY181 Aug 2017-2.2%-15.8%-8.8%1.2×
Q4 FY173 Jun 2017-0.7%+3.0%+2.7%0.5×
Q3 FY176 Feb 2017-1.0%-5.0%-8.1%0.7×
Q2 FY1722 Dec 2016-0.8%+1.0%-3.2%1.1×
Q1 FY171 Oct 2016+1.7%-0.9%+4.9%1.0×
Q4 FY1616 May 2016+2.9%+3.9%+5.9%1.9×
Q3 FY1610 Feb 20160.0%+7.6%+11.3%1.7×
Q2 FY1629 Oct 2015+1.4%-14.0%-23.9%2.0×
Q1 FY1631 Jul 2015+1.7%+4.5%+5.6%1.0×
Q4 FY1521 May 2015+0.3%-2.2%-6.4%0.6×
Q3 FY1529 Jan 2015+3.8%-5.2%+1.2%4.2×
Q2 FY1529 Oct 2014+1.6%+13.0%+19.1%1.4×
Q1 FY151 Aug 2014-1.8%-0.9%+6.6%1.1×
Q4 FY1413 May 2014-4.1%-14.7%-12.0%2.8×
Q3 FY1411 Feb 2014-1.7%+0.3%+2.5%1.6×
Q2 FY146 Nov 2013-0.4%+2.6%+0.4%0.6×
Q1 FY1430 Jul 2013+4.8%+3.6%+5.3%1.6×
Q4 FY1327 May 2013+1.2%+3.2%+0.4%1.6×
Q3 FY1321 Feb 2013-0.2%-3.8%-2.9%0.5×
Q2 FY1330 Oct 2012+1.6%+5.2%+6.5%2.1×
Q1 FY1319 Jul 2012-1.1%-3.0%-0.2%2.9×
Q4 FY1211 May 2012-2.2%-2.2%-4.5%3.0×
Q3 FY123 Feb 2012+2.4%-0.6%+3.2%4.9×
Q2 FY1225 Oct 2011+2.3%+6.2%-0.3%3.3×
Q1 FY1220 Jul 2011-2.1%-0.6%-8.5%1.5×
Q4 FY1113 May 2011+3.3%+0.2%-2.3%3.6×
Q3 FY1125 Jan 2011-3.5%-1.4%-3.5%2.9×
Q2 FY1123 Oct 2010+1.8%+4.3%+9.4%0.8×
Q1 FY1122 Jul 2010-1.7%-1.9%-4.6%1.7×
Q4 FY106 May 2010+0.1%+2.5%+12.5%2.3×
Q3 FY1020 Jan 2010+1.8%-2.3%-5.4%2.7×
Q2 FY1023 Oct 2009+6.3%+12.0%+22.3%1.7×
Q1 FY1021 Jul 2009-5.1%+1.7%+1.0%3.0×
Q4 FY0918 May 2009-3.4%+7.9%+16.3%2.8×
Q3 FY0920 Jan 2009-4.5%-3.2%-13.2%1.6×
Q2 FY0923 Oct 2008-3.1%-10.5%-10.4%1.6×
Q1 FY0921 Jul 2008+2.3%-5.0%-9.1%3.4×
Q4 FY0820 May 2008+3.0%+6.7%+7.9%1.8×
Q3 FY0825 Jan 2008-6.3%-13.2%-10.5%1.6×
Q2 FY0824 Oct 2007-2.7%-2.4%-4.1%2.2×
Q1 FY0823 Jul 2007+0.6%-5.1%-6.9%1.7×
Q4 FY0718 May 2007-1.1%-1.6%-5.3%2.0×
Average-0.0%-0.2%+0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY-1.5%
Profit YoY-31.3%
Interest cost YoY+40.3%
Revenue QoQ+7.4%
Profit QoQ+108.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+4.9%+7.3%+10.3%+10.1%+10.5%+10.4%
Profit-27.6%-18.1%-2.6%+7.4%+9.7%+0.3%

Key data

Open1,388.00
Day range1,384.80 – 1,400.00
52-week range1,101.00 – 1,414.90
From 52w high-1.7%
RSI (14)68.4
ATR (14)24.89
Volume8.31L
Avg volume (20D)19.70L
Rel volume0.42×
Volatility (1Y)24.1%
Turnover₹115.7Cr
Traded value (NSE)₹115.7Cr
VWAP1,392.27
SMA 50 / 2001,268.95 / 1,258.57
Price bandNo band
MWPL used22.3%

Delivery percentage

Latest · 20 Nov 202649.2%
20-day avg53.3%
1-year avg54.5%
Percentile (own history)45th
Range3.7–91.4%
Sessions3,629

Over the last 20 sessions DRREDDY settled 53.3% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 54.5%. The latest session ranks higher than 45% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.58%
Dividend, trailing 12M₹8.00
Paid every year for10+ yr
Shareholders4.77L · +6.9% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy3,809 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.76%+0.74%+12.20%+17.81%+5.44%+11.57%

Valuation

Market cap₹1.16L Cr
Market cap (NSE)₹1.16L Cr
Free-float cap₹85,197 Cr
P/E (TTM)41.5
P/E (NSE)42.4
EPS (TTM)33.52
P/B3.0
Net margin (TTM)8.5%
Other income / PBT35.6%
ROE7.5%
Debt / equity0.15
Shares outstanding83.50Cr
Listed30 May 2003

Ownership

Promoter26.63%
Promoter Δ QoQ-0.01 pp
Public73.17%
FII31.39%
DII31.88%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)8,753.47,546.48,099.88,697.8
YoY chg+4.4%-11.5%-5.5%-1.5%
Net profit (₹ Cr)1,189.6221.3435.6913.2
YoY chg-15.3%-86.1%-69.1%-31.7%
Net margin13.6%2.9%5.4%10.5%
EPS14.522.655.3311.09

Shareholding over time

By quarter

30 Sept 2026 · promoter 26.63% · public 73.17%
30 Sept 2021: promoter 26.72%31 Dec 2021: promoter 26.72%31 Mar 2022: promoter 26.72%30 Jun 2022: promoter 26.71%30 Sept 2022: promoter 26.71%31 Dec 2022: promoter 26.70%31 Mar 2023: promoter 26.70%30 Jun 2023: promoter 26.69%30 Sept 2023: promoter 26.66%31 Dec 2023: promoter 26.65%31 Mar 2024: promoter 26.65%30 Jun 2024: promoter 26.65%30 Sept 2024: promoter 26.64%31 Dec 2024: promoter 26.64%31 Mar 2025: promoter 26.64%30 Jun 2025: promoter 26.64%30 Sept 2025: promoter 26.64%31 Dec 2025: promoter 26.64%31 Mar 2026: promoter 26.63%30 Jun 2026: promoter 26.64%30 Sept 2026: promoter 26.63%
2021-092026-09
  • Promoter
  • Public and others
Promoter
26.63%
Public
73.17%
Promoter change
-0.01 pp
Filed
21 Oct 2026
FII
31.39%
DII
31.88%
Promoter pledged
0.00%

Who the public is

Mutual funds
14.14%

+0.98 pp QoQ

Insurance
14.59%

-0.65 pp QoQ

FPI
20.30%

-0.37 pp QoQ

Retail ≤ ₹2L
7.45%

+0.11 pp QoQ

HNI > ₹2L
0.08%

0.00 pp QoQ

NRI
0.93%

+0.02 pp QoQ

Bodies corporate
0.42%

+0.07 pp QoQ

Shareholders
4,76,681

+6.9% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
LIFE INSURANCE CORPORATION OF INDIA P & GS FUNDInsurance12.14%
GVP Family TrustPromoter · Other11.51%
J P Morgan Chase Bank NAForeign11.10%
VSD Family TrustPromoter · Other9.06%
ISIF EQUITY EX-TOP 100 LONG-SHORT FUNDMutual fund5.76%
KALLAM SATISH REDDY HUFPromoter · Individual3.31%
NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2Pension / PF2.93%
NIPPON LIFE INDIA TRUSTEE LTD-A/C-NIPPON INDIA NIFTY 50 VALUE 20 INDEX FUNDMutual fund1.58%
GUNUPATI VENKATESWARA PRASAD HUFPromoter · Individual1.52%
PARAG PARIKH FLEXI CAP FUNDMutual fund1.46%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 28 Jun 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹8.00₹8.00
FY2025-261₹8.00₹8.00
FY2024-251₹40.00₹8.00
FY2023-241₹40.00₹8.00
FY2022-231₹30.00₹6.00
FY2021-221₹25.00₹5.00
FY2020-211₹25.00₹5.00
FY2019-201₹20.00₹4.00
FY2018-191₹20.00₹4.00
FY2017-181₹20.00₹4.00
FY2016-171₹20.00₹4.00
FY2015-161₹20.00₹4.00
FY2014-151₹18.00₹3.60
FY2013-141₹15.00₹3.00
FY2012-131₹13.75₹2.75
Ex-dateRecord dateDeclaredAdjusted
10 Jul 2026—₹8.00₹8.00
10 Jul 2025—₹8.00₹8.00
16 Jul 2024—₹40.00₹8.00
11 Jul 2023—₹40.00₹8.00
11 Jul 2022—₹30.00₹6.00
9 Jul 2021—₹25.00₹5.00
13 Jul 2020—₹25.00₹5.00
15 Jul 2019—₹20.00₹4.00
16 Jul 2018—₹20.00₹4.00
17 Jul 2017—₹20.00₹4.00
18 Jul 2016—₹20.00₹4.00
10 Jul 2015—₹20.00₹4.00
11 Jul 2014—₹18.00₹3.60
12 Jul 2013—₹15.00₹3.00
28 Jun 2012—₹13.75₹2.75

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
5.8 years ago
Disclosures on record
1,362
16 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
4 Oct 2021C SwaminathanEmployeeSell489₹23.6L4,822.443.1K → 2.6K0.00%0.00 pp7(2)told 30 Sept 2021
29 Sept 2021Sanjay SharmaEmployeeSell1.0K₹49.1L4,910.003.2K → 2.2K0.00%0.00 pp7(2)told 29 Sept 2021
29 Sept 2021Dr. Reddy's Employees ESOS TrustOtherSell758₹36.4L4,798.184.90L → 4.90L0.30%-0.00 pp7(2)told 29 Sept 2021
27 Sept 2021Arun AnandRelativeSell300₹14.4L4,790.00515 → 2150.00%0.00 pp7(2)told 27 Sept 2021
27 Sept 2021Dr. Reddy's Employees ESOS TrustOtherSell374₹18.0L4,806.004.91L → 4.91L0.30%-0.00 pp7(2)told 24 Sept 2021
24 Sept 2021Bijaygopal ChakrabartiEmployeeSell705₹34.2L4,856.65705 → —0.00%7(2)told 23 Sept 2021
24 Sept 2021Dr. Reddy's Employees ESOS TrustOtherSell585₹28.3L4,838.014.92L → 4.91L0.30%-0.00 pp7(2)told 22 Sept 2021
17 Sept 2021C Nirmala RajuEmployeeSell300₹14.9L4,954.00338 → 380.00%0.00 pp7(2)told 17 Sept 2021
17 Sept 2021Satyanarayana SEmployeeSell1.0K₹49.7L4,968.004.1K → 3.1K0.00%0.00 pp7(2)told 16 Sept 2021
17 Sept 2021P Chandrasekhar ReddyEmployeeSell600₹29.8L4,959.90800 → 2000.00%0.00 pp7(2)told 15 Sept 2021
15 Sept 2021P Chandrasekhar ReddyEmployeeSell403₹20.0L4,956.401.2K → 8000.00%0.00 pp7(2)told 14 Sept 2021
15 Sept 2021H Rama MohanEmployeeSell400₹19.6L4,907.00795 → 3950.00%0.00 pp7(2)told 13 Sept 2021
13 Sept 2021John RoosenbergEmployeeSell335₹16.4L4,882.27335 → —0.00%7(2)told 9 Sept 2021
9 Sept 2021Dr. Reddy's Employees ESOS TrustOtherSell850₹41.6L4,895.024.93L → 4.93L0.30%-0.00 pp7(2)told 9 Sept 2021
6 Sept 2021Dr. Reddy's Employees ESOS TrustOtherSell472₹23.0L4,880.154.95L → 4.94L0.30%-0.00 pp7(2)told 6 Sept 2021
6 Sept 2021Dr. Reddy's Employees ESOS TrustOtherSell203₹9.9L4,880.154.95L → 4.95L0.30%-0.00 pp7(2)told 3 Sept 2021

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 9 Sept 2025

CSV
12 of 32 deals
By year
DateDealClientQuantityPriceValue
9 Sept 2025Buy · blockKAPITALFORENINGEN INVESTIN PRO5.81L1,250.60₹72.7Cr
9 Sept 2025Sell · blockKAPITALFORENINGEN PENSAM INVEST5.81L1,250.60₹72.7Cr
14 Jul 2025Buy · blockTHE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ4000458491.42L1,254.00₹17.8Cr
14 Jul 2025Sell · blockTHE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ4000458281.42L1,254.00₹17.8Cr
14 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.81L4,539.45₹82.0Cr
14 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.81L4,539.45₹82.0Cr
3 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.81L4,555.65₹82.3Cr
3 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.81L4,555.65₹82.3Cr
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.49L4,335.70₹64.8Cr
3 Oct 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.49L4,335.70₹64.8Cr
8 Aug 2022Sell · blockISHARES INDIA INDEX MAURITIUS COMPANY1.38L4,156.85₹57.2Cr
8 Aug 2022Buy · blockISHARES MSCI INDIA ETF1.38L4,156.85₹57.2Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to DRREDDY.

Price band: No band · not in the F&O ban · 22.3% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Short buildup — price down as fresh positions opened — new shorts.

Futures OI
1.76Cr

₹2,445.0Cr

OI change
+7.94%
Basis
-0.12%
Rollover
80.3%
PCR (OI)
0.78
PCR (volume)
0.62
Front settle
1,388.60
Lot size
625

shares

Futures volume
21.0K

contracts

Futures trades
16,799
Futures value
₹1,829.1Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 625

Put OICall OI
Max pain
1,350

-2.9% from spot

Call OI wall
1,400
Put OI wall
1,360
PCR (OI, this expiry)
0.83
PutsStrikeCalls
1,270
1,280
1,290
1,300
1,310
1,320
1,330
1,340
1,350MP
1,360PW
1,370
1,380
1,390
Spot 1,390.2
1,400CW
1,410
1,420
1,430
1,440
1,450
1,460
1,470
1,480
1,490
1,500
1,510

1,350: puts 2.97L OI (−27.5K), close 0.45, ₹103.1Cr notional in 867 trades · calls 2.26L OI (−21.9K), close 38.45, ₹9.1Cr notional in 99 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations7,236.87,113.87,696.18,038.28,381.28,528.48,572.18,828.38,753.47,546.48,099.88,697.8
Other income216.2197.5187.2307.5150.2522.1290.3323.9268.8475.4354.7156.2
Total income7,453.07,311.37,883.38,345.78,531.49,050.58,862.49,152.29,022.28,021.88,454.58,854.0
Total expenses5,626.65,709.66,006.66,434.46,661.37,050.86,957.67,413.77,481.37,826.77,902.07,618.7
└ Finance costs39.459.359.875.781.765.683.090.794.4105.7125.5124.8
└ Depreciation373.5367.7380.6397.0471.4454.7476.1504.6521.0557.1536.6526.7
Profit before tax1,826.41,601.71,876.71,911.31,870.11,999.71,904.81,738.51,540.9195.1552.51,235.3
Tax expense448.2295.4490.2575.5470.1418.5495.1408.0353.6(21.6)117.7314.4
Net profit1,380.91,309.81,392.41,341.91,404.21,586.71,409.91,336.81,189.6221.3435.6913.2
EPS16.5915.7316.723.0216.9719.1217.0416.1814.532.655.3311.10
Net margin19.08%18.41%18.09%16.69%16.75%18.60%16.45%15.14%13.59%2.93%5.38%10.50%
PBT margin25.24%22.52%24.39%23.78%22.31%23.45%22.22%19.69%17.60%2.59%6.82%14.20%
Tax rate24.54%18.44%26.12%30.11%25.14%20.93%25.99%23.47%22.95%-11.07%21.30%25.45%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 23 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets32,285.134,809.438,863.846,728.449,426.654,373.258,123.457,631.3
Current assets20,694.221,769.524,805.325,047.725,018.127,955.830,179.329,732.2
└ Cash & equivalents577.91,353.9710.71,133.01,465.4990.61,536.81,329.4
└ Other bank balances1,152.31,574.01,017.0895.4994.81,055.81,811.92,263.2
└ Current investments4,449.63,865.04,405.03,064.73,330.73,921.63,823.33,281.6
└ Trade receivables7,248.56,972.28,029.88,439.89,042.09,775.410,123.410,139.9
└ Inventories4,867.05,659.26,355.27,203.97,108.57,582.27,653.48,118.2
Total equity23,286.125,496.828,254.831,143.233,927.436,373.338,230.939,126.1
└ Attributable to owners23,286.125,496.828,254.830,749.333,549.636,014.037,891.538,807.0
└ Non-controlling interest—0.00.0393.9377.8359.3339.4319.1
└ Share capital83.383.483.483.483.483.583.583.5
Borrowings1,347.21,323.01,652.34,382.24,184.54,495.66,293.55,826.0
└ Current1,219.4718.71,272.34,002.23,804.54,495.66,293.55,826.0
└ Non-current127.8604.3380.0380.0380.00.00.00.0
Trade payables2,268.42,725.22,614.43,020.62,647.83,532.33,037.93,236.3
Current liabilities8,572.18,406.59,588.012,920.713,033.815,104.116,747.415,430.3
Total liabilities8,999.09,312.610,609.015,585.215,499.217,999.919,892.518,505.2
Net debt(4,832.6)(5,469.9)(4,480.4)(710.9)(1,606.4)(1,472.4)(878.5)(1,048.2)
Debt / equity0.060.050.060.140.120.120.160.15
Current ratio2.412.592.591.941.921.851.801.93

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow5,887.32,917.64,543.31,781.14,642.83,020.25,673.7434.8
└ Capex(1,886.4)(1,611.0)(2,743.5)(1,433.3)(3,439.8)(2,028.4)(3,840.5)(801.8)
Free cash flow4,000.91,306.61,799.8347.81,203.0991.81,833.2(367.0)
Investing cash flow(4,137.1)(1,275.3)(4,028.3)(3,931.9)(5,102.1)(2,873.5)(6,549.3)812.4
Financing cash flow(2,686.1)(851.2)(376.3)2,569.11,185.5(652.6)829.0(1,468.6)
└ Dividends paid(497.9)(664.8)(664.8)(666.2)(666.2)(665.9)(665.9)(666.4)
└ Buybacks0.00.00.00.0(138.9)0.00.00.0
Net change in cash(907.3)775.6132.8417.8748.6(505.9)(46.6)(217.8)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

DRREDDY at a glance

  • DRREDDY closed at ₹1,390.2 on 20 Nov 2026, -0.76% on the day, +11.6% over one year, 1.7% below its 52-week high of ₹1,414.9.
  • Delivery was 49.2% of traded quantity on 20 Nov 2026, the 45th percentile of its own 3,629 sessions with a reading (20-session average 53.3%, 1-year average 54.5%).
  • Market capitalisation is ₹1.16 lakh crore at a trailing P/E of 41.5 (trailing EPS ₹33.52).
  • Q2 FY27 results (consolidated, filed 23 Oct 2026): revenue ₹8,698 crore (-1.5% year on year), net profit ₹913 crore (-31.7%); the price moved +6.6% on the first session after.
  • Promoters held 26.63% at 30 Sept 2026, down 0.01 percentage points on the previous filing.
  • Q3 FY27 results are expected between 21 Jan 2027 and 30 Jan 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE089A01031
SeriesEQ
Listed30 May 2003
NSE market cap · 17 Nov 2026₹1.16L Cr
Free-float market cap (NSE)₹84,481 Cr
Shares outstanding (NSE)83.53Cr
History from2 Jan 1995
Sessions7,885
Turnover rank#104

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.